Healthscope: Gordon Ballantyne to succeed Robert Cook as CEO/MD

Company News

by Jessica Amir

Healthscope Limited (ASX:HSO) has announced Gordon Ballantyne will replace Robert Cook as the company’s Managing Director and Chief Executive Officer effective from 15 May 2017.

Incoming Gordon Ballantyne was previously a Group Executive of Telstra (ASX:TLS), where he led a large scale cultural transformation that grew the retail business to $18 billion.

The private hospital and medical centre operator says Gordon Ballantyne also helped Telstra deliver years of double-digit revenue growth, while he also founded Telstra Health.

Outgoing CEO and MD Robert Cook has been with Healthscope for over six years and also led the company to more than double its EBITDA from the 2011 to 2016 to $408 million

Shares in Healthscope Limited (ASX:HSO) are trading 2.6% lower to $2.21
 

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.